The DOI matches its Crossref record; 767 of the 767 references it cites were found in a registry or an index.
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Open accessAbstract
Depression is a multicausal disorder and has been associated with the risk to develop cancer, dementia, diabetes, epilepsy and stroke. As a metabolic disorder depression has been associated with obesity, diabetes, insulin sensitivity, neuropeptide Y, glucose regulation, poor glycemic control, glucagone-like peptide-1, cholezystokinin, ghrelin, leptin, the endocannabinoid system, insulin-like growth factor and gastrin-releasing peptide. As a cardiovascular disease a close relationship exists between depression and blood pressure, heart rate, norepinephrine, sympathetic tone, vascular resistance, blood viscosity, plasma volume, intima thickness and atherosclerosis. Additionally blood coagulation, fibrinolysis, D-dimers, plasminogen activator inhibitor-1 protein, platelet activation, VEGF, plasma nitric oxide and its synthase are changed in depressed patients. As an endocrinological and stress disorder depression has been connected with the concentration of free T4, TSH, CRH, arginine vasopressin, corticotrophin, corticosteroid release and ACTH. Depression as an inflammatory disorder is mediated by pro-inflammatory cytokines, interleukin-1, interleukin-6, TNF-alpha, soluble interleukin-2 receptors, interferon-alpha, interleukin 8, interleukin-10, hs-CRP, acute phase proteins, haptoglobin, toll like receptor 4, interleukin-1beta, mammalian target of rapamycin pathway, substance P, cyclooxygenase-2, prostaglandin-E2, lipid peroxidation levels and acid sphingomyelinase. Nutritional factors might influence depression risk, i.e. the consumption of folate, omega-3 fatty acids, monounsaturated fatty acids, olive oil, fish, fruits, vegetables, nuts, legumes, vitamin B6 and vitamin B12. The neurodegenerative hypothesis of depression explains decreased hippocampal volumes in depressed patients and changes of neurotrophic support by BDNF, erythropoietin, GDNF, FGF-2, NT3, NGF and growth hormone. In this context, a fast neuroprotective and antidepressant effect has also been observed by ketamine, which acts via the glutamatergic system. Hence, GABA, AMPA, EAAT, NMDA- and metabotropic glutamate receptors (mGluR1 to mGluR8) have gained interest in depression recently. Alternative, causative or also easy available treatment strategies beyond serotonin and noradrenaline reuptake inhibition might be a major topic of future psychiatric care. In this review, an attempt is made to overview concepts of the disease and search for perspectives on antidepressant treatment strategies beyond approved medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antiglucocorticoid treatments for mood disorders
Gallagher, P., Malik, N., Newham, J. J., Young, A. H., Ferrier, I. N., & Mackin, P. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005168.pub2 · Cited by 97
RetractedMeasurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Establishing a standard definition for child overweight and obesity worldwide: international survey
Cole, T. J. (2000) · BMJ · doi:10.1136/bmj.320.7244.1240 · Cited by 16,480
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
Hills, A. P., Byrne, N. M., Lindstrom, R., & Hill, J. O. (2013) · Obesity Facts · doi:10.1159/000345030 · Cited by 9,493
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Cited by
Items 901–1,000 of 1,222
Szymocha, R., Akaoka, H., Dutuit, M., Malcus, C., Didier-Bazes, M., Belin, M.-F., & Giraudon, P. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6433-6441.2000 · Cited by 83
Kondo, D. G., Forrest, L. N., Shi, X., Sung, Y.-H., Hellem, T. L., Huber, R. S., & Renshaw, P. F. (2016) · Amino Acids · doi:10.1007/s00726-016-2194-3 · Cited by 79
Satiety: a gut–brain–relationship
Barakat, G. M., Ramadan, W., Assi, G., & Khoury, N. B. E. (2024) · The Journal of Physiological Sciences · doi:10.1186/s12576-024-00904-9 · Cited by 82
Ng, L. H. L., Huang, Y., Han, L., Chang, R. C.-C., Chan, Y. S., & Lai, C. S. W. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0321-5 · Cited by 82
Davis, L. M., Michaelides, M., Cheskin, L. J., Moran, T. H., Aja, S., Watkins, P. A., Pei, Z., Contoreggi, C., McCullough, K., Hope, B., et al. (2009) · Neuroendocrinology · doi:10.1159/000170586 · Cited by 82
Zanos, P., Highland, J. N., Liu, X., Troppoli, T. A., Georgiou, P., Lovett, J., Morris, P. J., Stewart, B. W., Thomas, C. J., Thompson, S. M., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14683 · Cited by 82
Price, R. B., Kissel, N., Baumeister, A., Rohac, R., Woody, M. L., Ballard, E. D., Zarate, C. A., Deakin, W., Abdallah, C. G., Feder, A., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01757-7 · Cited by 82
Plasma BDNF levels vary in relation to body weight in females
Pillai, A., Bruno, D., Sarreal, A. S., Hernando, R. T., Saint-Louis, L. A., Nierenberg, J., Ginsberg, S. D., Pomara, N., Mehta, P. D., Zetterberg, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039358 · Cited by 82
Fogaça, M. V., Fukumoto, K., Franklin, T., Liu, R.-J., Duman, C. H., Vitolo, O. V., & Duman, R. S. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0501-x · Cited by 82
Dwyer, J. M., Lepack, A. E., & Duman, R. S. (2013) · Journal of Molecular Psychiatry · doi:10.1186/2049-9256-1-15 · Cited by 81
Liu, J. P., Clarke, I. J., Funder, J. W., & Engler, D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117121 · Cited by 81
Lazarevic, V., Yang, Y., Flais, I., & Svenningsson, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01246-3 · Cited by 81
The influence of ketamine on drug discovery in depression
Kraus, C., Wasserman, D., Henter, I. D., Acevedo-Diaz, E., Kadriu, B., & Zarate, C. A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.07.007 · Cited by 75
Li, W., Ali, T., Zheng, C., He, K., Liu, Z., Shah, F. A., Li, N., Yu, Z.-J., & Li, S. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01327-3 · Cited by 80
Martín-Hernández, D., Caso, J. R., Javier Meana, J., Callado, L. F., Madrigal, J. L. M., García-Bueno, B., & Leza, J. C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1294-2 · Cited by 80
Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0081-2 · Cited by 80
iPlasticity: Induced juvenile‐like plasticity in the adult brain as a mechanism of antidepressants
Umemori, J., Winkel, F., Didio, G., Llach Pou, M., & Castrén, E. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12683 · Cited by 80
Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression
Michel, M., Fiebich, B. L., Kuzior, H., Meixensberger, S., Berger, B., Maier, S., Nickel, K., Runge, K., Denzel, D., Pankratz, B., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01423-6 · Cited by 79
A randomized dose-ranging study of neuropeptide Y in patients with posttraumatic stress disorder
Sayed, S., Van Dam, N. T., Horn, S. R., Kautz, M. M., Parides, M., Costi, S., Collins, K. A., Iacoviello, B., Iosifescu, D. V., Mathé, A. A., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx109 · Cited by 79
Statin use and risk of depression: a Swedish national cohort study
Redlich, C., Berk, M., Williams, L. J., Sundquist, J., Sundquist, K., & Li, X. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0348-y · Cited by 76
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76
Pharmacological approaches to the management of binge eating disorder
Brownley, K. A., Peat, C. M., La Via, M., & Bulik, C. M. (2015) · Drugs · doi:10.1007/s40265-014-0327-0 · Cited by 78
Gender Differences in the Neurobiology of Anxiety: Focus on Adult Hippocampal Neurogenesis
Marques, A. A., Bevilaqua, M. C. D. N., da Fonseca, A. M. P., Nardi, A. E., Thuret, S., & Dias, G. P. (2016) · Neural Plasticity · doi:10.1155/2016/5026713 · Cited by 78
Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior
Dwyer, J. M., Maldonado-Avilés, J. G., Lepack, A. E., DiLeone, R. J., & Duman, R. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505289112 · Cited by 76
Creatine for the Treatment of Depression
Kious, B. M., Kondo, D. G., & Renshaw, P. F. (2019) · Biomolecules · doi:10.3390/biom9090406 · Cited by 74
Inflammation and depression: Is there a causal connection with dementia?
E.Leonard, B., & Myint, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033243 · Cited by 76
Beurel, E., Grieco, S. F., Amadei, C., Downey, K., & Jope, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12436 · Cited by 76
El Iskandrani, K. S., Oosterhof, C. A., El Mansari, M., & Blier, P. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573809 · Cited by 75
Kang, M. J. Y., Hawken, E., & Vazquez, G. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.860882 · Cited by 77
Richards, E. M., Mathews, D. C., Luckenbaugh, D. A., Ionescu, D. F., Machado-Vieira, R., Niciu, M. J., Duncan, W. C., Nolan, N. M., Franco-Chaves, J. A., Hudzik, T., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4195-4 · Cited by 76
Roberts, R. C., Roche, J. K., & McCullumsmith, R. E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.019 · Cited by 76
Zelikoff, J. T., Parmalee, N. L., Corbett, K., Gordon, T., Klein, C. B., & Aschner, M. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx257 · Cited by 76
Medeiros, G. C., Gould, T. D., Prueitt, W. L., Nanavati, J., Grunebaum, M. F., Farber, N. B., Singh, B., Selvaraj, S., Machado-Vieira, R., Achtyes, E. D., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01652-1 · Cited by 75
Jett, J. D., Boley, A. M., Girotti, M., Shah, A., Lodge, D. J., & Morilak, D. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3957-3 · Cited by 75
Stuart, S. A., Butler, P., Munafò, M. R., Nutt, D. J., & Robinson, E. S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.59 · Cited by 71
Sekio, M., & Seki, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu005 · Cited by 75
New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity
Huang, Y.-J., Lane, H.-Y., & Lin, C.-H. (2017) · Neural Plasticity · doi:10.1155/2017/4605971 · Cited by 74
Acute Changes in Striatal Microstructure Predict the Development of Interferon-Alpha Induced Fatigue
Dowell, N. G., Cooper, E. A., Tibble, J., Voon, V., Critchley, H. D., Cercignani, M., & Harrison, N. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.015 · Cited by 74
Mehta, D., Raison, C. L., Woolwine, B. J., Haroon, E., Binder, E. B., Miller, A. H., & Felger, J. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.004 · Cited by 74
Jago, R., Solomon-Moore, E., Macdonald-Wallis, C., Sebire, S. J., Thompson, J. L., & Lawlor, D. A. (2017) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-017-0492-0 · Cited by 74
Christian, L. M., Mitchell, A. M., Gillespie, S. L., & Palettas, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.025 · Cited by 73
Walsh, E., Eisenlohr-Moul, T., & Baer, R. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000122 · Cited by 72
Haghighi, F., Galfalvy, H., Chen, S., Huang, Y.-Y., Cooper, T. B., Burke, A. K., Oquendo, M. A., Mann, J. J., & Sublette, M. E. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00092 · Cited by 73
Treccani, G., Ardalan, M., Chen, F., Musazzi, L., Popoli, M., Wegener, G., Nyengaard, J. R., & Müller, H. K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1613-3 · Cited by 73
Cummings, D. M., Kirian, K., Howard, G., Howard, V., Yuan, Y., Muntner, P., Kissela, B., Redmond, N., Judd, S. E., & Safford, M. M. (2016) · Diabetes Care · doi:10.2337/dc15-1174 · Cited by 73
Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
Yimer, E. M., Hishe, H. Z., & Tuem, K. B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00236 · Cited by 72
Targeting cytokines in reduction of depressive symptoms: A comprehensive review
Shariq, A. S., Brietzke, E., Rosenblat, J. D., Barendra, V., Pan, Z., & McIntyre, R. S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.003 · Cited by 72
“On the other hand, other individuals display significant symptomatic improvement, implying the possibility of mechanistic variations in disease pathology, suggesting an unexplored potential in stratified and personalized treatment approaches for people with MDD (Lang and Borgwardt, 2013).”
Chen, Z., Peng, W., Sun, H., Kuang, W., Li, W., Jia, Z., & Gong, Q. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.209 · Cited by 70
Antidepressants for the treatment of depression in people with cancer
Vita, G., Compri, B., Matcham, F., Barbui, C., & Ostuzzi, G. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub4 · Cited by 73
Barlinn, K., Kepplinger, J., Puetz, V., Illigens, B., Bodechtel, U., & Siepmann, T. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s63904 · Cited by 72
Lucidi‐Phillipi, C. A., Gage, F. H., Shults, C. W., Jones, K. R., Reichardt, L. F., & Kang, U. J. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903540306 · Cited by 72
Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review
Salahudeen, M. S., Wright, C. M., & Peterson, G. M. (2020) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098620937899 · Cited by 72
The Role of Anxious Distress in Immune Dysregulation in Patients with Major Depressive Disorder
Gaspersz, R., Lamers, F., Wittenberg, G., Beekman, A. T. F., van Hemert, A. M., Schoevers, R. A., & Penninx, B. W. J. H. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0016-3 · Cited by 71
Dogra, S., & Conn, P. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108687 · Cited by 71
Abdallah, C. G., Jackowski, A., Sato, J. R., Mao, X., Kang, G., Cheema, R., Coplan, J. D., Mathew, S. J., & Shungu, D. C. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.025 · Cited by 67
Cheng, Y., Jope, R. S., & Beurel, E. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0169-z · Cited by 70
Kuang, W.-H., Dong, Z.-Q., Tian, L.-T., & Li, J. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20187212 · Cited by 70
Mindfulness training for healthy aging: impact on attention, well-being, and inflammation.
Fountain-Zaragoza, S., & Prakash, R. S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00011 · Cited by 66
Glutamatergic Modulators for Major Depression from Theory to Clinical Use
McIntyre, R. S., & Jain, R. (2024) · CNS Drugs · doi:10.1007/s40263-024-01114-y · Cited by 69
Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms
Hare, B. D., Ghosal, S., & Duman, R. S. (2017) · Chronic Stress · doi:10.1177/2470547017697317 · Cited by 67
Kuhlman, K. R., Robles, T. F., Dooley, L. N., Boyle, C. C., Haydon, M. D., & Bower, J. E. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.001 · Cited by 67
Homer1/mGluR5 Activity Moderates Vulnerability to Chronic Social Stress
Wagner, K. V., Hartmann, J., Labermaier, C., Häusl, A. S., Zhao, G., Harbich, D., Schmid, B., Wang, X.-D., Santarelli, S., Kohl, C., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.308 · Cited by 67
Cigarette Smoking and Brain Regulation of Energy Homeostasis
Chen, H., Saad, S., Sandow, S. L., & Bertrand, P. P. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00147 · Cited by 69
Kaut, O., Schmitt, I., Hofmann, A., Hoffmann, P., Schlaepfer, T. E., Wüllner, U., & Hurlemann, R. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0572-y · Cited by 68
Banks, S. J., Raman, R., He, F., Salmon, D. P., Ferris, S., Aisen, P., & Cummings, J. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000357775 · Cited by 68
Piantadosi, S. C., French, B. J., Poe, M. M., Timić, T., Marković, B. D., Pabba, M., Seney, M. L., Oh, H., Orser, B. A., Savić, M. M., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00446 · Cited by 67
Pharmacologic Interventions for Fatigue in Cancer and Transplantation: A Meta-Analysis
Tomlinson, D., Robinson, P. D., Oberoi, S., Cataudella, D., Culos-Reed, N., Davis, H., Duong, N., Gibson, F., Götte, M., Hinds, P., et al. (2018) · Current Oncology · doi:10.3747/co.25.3883 · Cited by 68
Treatment for Substance Use Disorder with Co-Occurring Mental Illness
Iqbal, M. N., Levin, C. J., & Levin, F. R. (2019) · Focus · doi:10.1176/appi.focus.20180042 · Cited by 66
Brain arousal regulation as response predictor for antidepressant therapy in major depression
Schmidt, F. M., Sander, C., Dietz, M.-E., Nowak, C., Schröder, T., Mergl, R., Schönknecht, P., Himmerich, H., & Hegerl, U. (2017) · Scientific Reports · doi:10.1038/srep45187 · Cited by 61
Tartter, M., Hammen, C., Bower, J. E., Brennan, P. A., & Cole, S. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.01.003 · Cited by 66
Mac Giollabhui, N., Hamilton, J. L., Nielsen, J., Connolly, S. L., Stange, J. P., Varga, S., Burdette, E., Olino, T. M., Abramson, L. Y., & Alloy, L. B. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000301 · Cited by 66
Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain Stimulation
Etiévant, A., Oosterhof, C., Bétry, C., Abrial, E., Novo-Perez, M., Rovera, R., Scarna, H., Devader, C., Mazella, J., Wegener, G., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.06.023 · Cited by 65
Vande Voort, J. L., Ballard, E. D., Luckenbaugh, D. A., Bernert, R. A., Richards, E. M., Niciu, M. J., Park, L. T., Machado-Vieira, R., Duncan, W. C., & Zarate, C. A. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10440 · Cited by 65
Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action
Du, J., Machado-Vieira, R., Maeng, S., Martinowich, K., Manji, H. K., & Zarate, C. A. (2006) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2006.11.012 · Cited by 64
Huang, C., Zhang, F., Li, P., & Song, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213856 · Cited by 65
Limon, A., Mamdani, F., Hjelm, B. E., Vawter, M. P., & Sequeira, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.010 · Cited by 63
Szentirmai, É., Massie, A. R., & Kapás, L. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.12.008 · Cited by 64
Bioactive lipids as modulators of immunity, inflammation and emotions
Chiurchiù, V., & Maccarrone, M. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.06.005 · Cited by 64
Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closure
Corcelle-Termeau, E., Vindeløv, S. D., Hämälistö, S., Mograbi, B., Keldsbo, A., Bräsen, J. H., Favaro, E., Adam, D., Szyniarowski, P., Hofman, P., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1159378 · Cited by 64
Centanni, S. W., Bedse, G., Patel, S., & Winder, D. G. (2019) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.14178 · Cited by 58
Tobacco use in bipolar disorder
Thomson, D., Berk, M., Dodd, S., Rapado-Castro, M., Quirk, S. E., Ellegaard, P. K., Berk, L., & Dean, O. M. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.1.1 · Cited by 63
Milak, M. S., Rashid, R., Dong, Z., Kegeles, L. S., Grunebaum, M. F., Ogden, R. T., Lin, X., Mulhern, S. T., Suckow, R. F., Cooper, T. B., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13211 · Cited by 63
Microglial Function during Glucose Deprivation: Inflammatory and Neuropsychiatric Implications
Churchward, M. A., Tchir, D. R., & Todd, K. G. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0422-9 · Cited by 63
Wang, H., Warner-Schmidt, J., Varela, S., Enikolopov, G., Greengard, P., & Flajolet, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510291112 · Cited by 63
Johnson-Farley, N. N., Travkina, T., & Cowen, D. S. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094433 · Cited by 63
Frederiksen, H. R., Haukedal, H., & Freude, K. (2019) · BioMed Research International · doi:10.1155/2019/7420189 · Cited by 63
Park, L. T., Kadriu, B., Gould, T. D., Zanos, P., Greenstein, D., Evans, J. W., Yuan, P., Farmer, C. A., Oppenheimer, M., George, J. M., et al. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa025 · Cited by 63
Jeon, S.-A., Lee, E., Hwang, I., Han, B., Park, S., Son, S., Yang, J., Hong, S., Kim, C. H., Son, J., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx065 · Cited by 62
Depression as sickness behavior? A test of the host defense hypothesis in a high pathogen population
Stieglitz, J., Trumble, B. C., Thompson, M. E., Blackwell, A. D., Kaplan, H., & Gurven, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.05.008 · Cited by 62
Taniguti, E. H., Ferreira, Y. S., Stupp, I. J. V., Fraga-Junior, E. B., Mendonça, C. B., Rossi, F. L., Ynoue, H. N., Doneda, D. L., Lopes, L., Lima, E., et al. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.02.034 · Cited by 62
Serotonin 6 receptor controls alzheimer’s disease and depression
Yun, H.-M., Park, K.-R., Kim, E.-C., Kim, S., & Hong, J. T. (2015) · Oncotarget · doi:10.18632/oncotarget.5777 · Cited by 62
Anticipated brain molecular aging in major depression
Douillard-Guilloux, G., Guilloux, J.-P., Lewis, D. A., & Sibille, E. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.040 · Cited by 62
Kadriu, B., Musazzi, L., Johnston, J. N., Kalynchuk, L. E., Caruncho, H. J., Popoli, M., & Zarate, C. A. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.027 · Cited by 62
Greenwood, B. N., Strong, P. V., Foley, T. E., Thompson, R. S., & Fleshner, M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.007 · Cited by 61
Brooker, S. M., Gobeske, K. T., Chen, J., Peng, C.-Y., & Kessler, J. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.160 · Cited by 61
Pringle, A., & Harmer, C. J. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.4/apringle · Cited by 61
Kopelman, J., Keller, T. A., Panny, B., Griffo, A., Degutis, M., Spotts, C., Cruz, N., Bell, E., Do-Nguyen, K., Wallace, M. L., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02451-0 · Cited by 60
Ding, Y., Chang, L.-C., Wang, X., Guilloux, J.-P., Parrish, J., Oh, H., French, B. J., Lewis, D. A., Tseng, G. C., & Sibille, E. (2015) · Complex Psychiatry · doi:10.1159/000369974 · Cited by 61
Iglewicz, A., Morrison, K., Nelesen, R. A., Zhan, T., Iglewicz, B., Fairman, N., Hirst, J. M., & Irwin, S. A. (2015) · Psychosomatics · doi:10.1016/j.psym.2014.05.005 · Cited by 60
Ketamine regulates the presynaptic release machinery in the hippocampus
Müller, H. K., Wegener, G., Liebenberg, N., Zarate, C. A., Popoli, M., & Elfving, B. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.008 · Cited by 61
Metadata
- Authors
- Lang, U. E., & Borgwardt, S.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 31
- Issue
- 6
- Pages
- 761-777
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2003982930
- Cited by
- 8,475
- References
- 767
- FWCI
- 416.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.